ABT vs. ZS
ABT (Abbott Laboratories) and ZS (Zscaler, Inc.) are both stocks. ABT operates in Medical Devices (Healthcare), while ZS operates in Software - Infrastructure (Technology). Over the past 5 years, ABT returned -2.50%/yr vs -9.02%/yr for ZS. At a 0.25 correlation, their price movements are largely independent.
Performance
ABT vs. ZS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABT achieves a -28.82% return, which is significantly higher than ZS's -42.42% return.
ABT
- 1D
- -1.64%
- 1M
- 4.39%
- YTD
- -28.82%
- 6M
- -28.92%
- 1Y
- -33.65%
- 3Y*
- -2.76%
- 5Y*
- -2.50%
- 10Y*
- 10.94%
ZS
- 1D
- 2.70%
- 1M
- -19.58%
- YTD
- -42.42%
- 6M
- -45.18%
- 1Y
- -57.11%
- 3Y*
- -6.33%
- 5Y*
- -9.02%
- 10Y*
- —
ABT vs. ZS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | -28.82% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 17.12% |
ZS Zscaler, Inc. | -42.42% | 24.67% | -18.57% | 98.00% | -65.18% | 60.90% | 329.48% | 18.59% | 42.58% |
Correlation
The correlation between ABT and ZS is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Mar 16, 2018 | 0.25 |
The correlation between ABT and ZS shifts across timeframes, from -0.01 (1 year) to 0.25 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ABT:
$154.05B
ZS:
$20.82B
ABT:
$3.59
ZS:
-$0.49
ABT:
3.42
ZS:
6.48
ABT:
2.33
ZS:
8.80
ABT:
$45.13B
ZS:
$3.17B
ABT:
$25.45B
ZS:
$2.43B
ABT:
$10.80B
ZS:
$69.08M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABT vs. ZS — Risk / Return Rank
ABT
ZS
ABT vs. ZS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Zscaler, Inc. (ZS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABT | ZS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.42 | ||
| Sortino ratioReturn per unit of downside risk | -0.59 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 0.79 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | -0.88 | -0.88 | 0.00 |
| Martin ratioReturn relative to average drawdown | -1.92 | -1.55 | -0.37 |
Loading charts...
Drawdowns
ABT vs. ZS - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum ZS drawdown of -76.41%. Use the drawdown chart below to compare losses from any high point for ABT and ZS.
Loading charts...
Drawdown Indicators
| ABT | ZS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.66% | -76.41% | +30.75% |
Max Drawdown (1Y)Largest decline over 1 year | -38.99% | -64.89% | +25.90% |
Max Drawdown (3Y)Largest decline over 3 years | -39.64% | -64.89% | +25.25% |
Max Drawdown (5Y)Largest decline over 5 years | -39.64% | -76.41% | +36.77% |
Max Drawdown (10Y)Largest decline over 10 years | -39.64% | — | — |
Current DrawdownCurrent decline from peak | -35.53% | -64.88% | +29.35% |
Average DrawdownAverage peak-to-trough decline | -10.84% | -32.68% | +21.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.75% | 36.90% | -19.15% |
Volatility
ABT vs. ZS - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 7.71%, while Zscaler, Inc. (ZS) has a volatility of 44.34%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than ZS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABT | ZS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.71% | 44.34% | -36.63% |
Volatility (6M)Calculated over the trailing 6-month period | 19.48% | 57.43% | -37.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 58.73% | -34.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.06% | 56.07% | -34.01% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.67% | 58.78% | -35.11% |
Dividends
ABT vs. ZS - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.77%, while ZS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.77% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
ZS Zscaler, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
ABT vs. ZS - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Zscaler, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABT vs. ZS - Profitability Comparison
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.
ZS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Zscaler, Inc. reported a gross profit of 657.82M and revenue of 850.48M. Therefore, the gross margin over that period was 77.4%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.
ZS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Zscaler, Inc. reported an operating income of -29.64M and revenue of 850.48M, resulting in an operating margin of -3.5%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.
ZS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Zscaler, Inc. reported a net income of -13.88M and revenue of 850.48M, resulting in a net margin of -1.6%.
Frequently Asked Questions
ABT and ZS have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZS has higher volatility (44.34%) compared to ABT (7.71%). In terms of maximum drawdown, ABT dropped -45.66% vs ZS's -76.41%.
ZS currently has the higher Sharpe Ratio (-0.97 vs -1.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABT and ZS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer